Phibro Animal Health Corp. (NASDAQ:PAHC) updated its FY17 earnings guidance on Wednesday. The company provided EPS guidance of $1.38-1.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.41. The company issued revenue guidance of $750-770 million, compared to the consensus revenue estimate of $760.16 million.

A number of research analysts have issued reports on PAHC shares. Morgan Stanley set a $23.00 price target on Phibro Animal Health Corp. and gave the company a sell rating in a report on Sunday, September 4th. Gabelli downgraded Phibro Animal Health Corp. from a buy rating to a hold rating in a report on Thursday. Zacks Investment Research downgraded Phibro Animal Health Corp. from a hold rating to a sell rating in a report on Tuesday, August 23rd. Credit Suisse Group AG reissued a buy rating and issued a $29.00 price target on shares of Phibro Animal Health Corp. in a report on Tuesday, August 30th. Finally, TheStreet raised Phibro Animal Health Corp. from a sell rating to a hold rating in a report on Wednesday, September 14th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company’s stock. Phibro Animal Health Corp. has an average rating of Hold and a consensus price target of $30.67.

Shares of Phibro Animal Health Corp. (NASDAQ:PAHC) opened at 29.55 on Friday. The stock has a 50 day moving average price of $26.38 and a 200-day moving average price of $22.29. The stock has a market capitalization of $1.16 billion, a PE ratio of 14.28 and a beta of 1.38. Phibro Animal Health Corp. has a 52-week low of $16.80 and a 52-week high of $35.69.

Phibro Animal Health Corp. (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, November 9th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.02. The firm had revenue of $188 million for the quarter, compared to the consensus estimate of $188.85 million. Phibro Animal Health Corp. had a return on equity of 105.21% and a net margin of 11.02%. The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter last year, the business posted $0.44 EPS. On average, equities research analysts anticipate that Phibro Animal Health Corp. will post $1.41 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 21st. Investors of record on Wednesday, November 30th will be paid a dividend of $0.10 per share. The ex-dividend date is Monday, November 28th. This represents a $0.40 dividend on an annualized basis and a yield of 1.35%. Phibro Animal Health Corp.’s dividend payout ratio is presently 19.42%.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PAHC. Nuveen Fund Advisors LLC purchased a new position in Phibro Animal Health Corp. during the second quarter worth about $196,000. Nationwide Fund Advisors increased its position in Phibro Animal Health Corp. by 5.6% in the second quarter. Nationwide Fund Advisors now owns 11,921 shares of the company’s stock worth $222,000 after buying an additional 637 shares in the last quarter. Highbridge Capital Management LLC purchased a new position in Phibro Animal Health Corp. during the second quarter worth about $232,000. American International Group Inc. increased its position in Phibro Animal Health Corp. by 4.2% in the second quarter. American International Group Inc. now owns 13,909 shares of the company’s stock worth $260,000 after buying an additional 564 shares in the last quarter. Finally, Clinton Group Inc. purchased a new position in Phibro Animal Health Corp. during the second quarter worth about $379,000. Hedge funds and other institutional investors own 47.99% of the company’s stock.

About Phibro Animal Health Corp.

Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.

5 Day Chart for NASDAQ:PAHC

Receive News & Stock Ratings for Phibro Animal Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp. and related stocks with our FREE daily email newsletter.